Cancer Screening Explained: Why Early Detection Saves Lives
The Screening Principle
Cancer screening is the systematic testing of people without symptoms to find cancer at an early stage, when treatment is more likely to succeed. The principle is simple: most cancers are more treatable before they spread. A tumor confined to the breast or colon can often be removed surgically. Once it metastasizes to distant organs, treatment becomes much harder.
But screening is not without trade-offs. Every screening test produces false positives — results that suggest cancer where none exists — leading to unnecessary biopsies, anxiety, and procedures. Overdiagnosis occurs when screening detects a cancer that would never have caused symptoms or death during the person's lifetime. The challenge is designing screening programs that maximize lives saved while minimizing harm from false positives and overtreatment.
The Major Screening Programs
Breast cancer screening via mammography is recommended every one to two years for women starting at age 40 or 50, depending on the country and risk factors. The evidence shows that mammography reduces breast cancer mortality by roughly 20 to 30 percent in screened populations. The controversy is about the starting age and frequency, with different national guidelines reflecting different judgments about the balance of benefit and harm.
Colorectal cancer screening via colonoscopy or stool-based tests is recommended starting at age 45. Colonoscopy can detect and remove precancerous polyps during the same procedure, actually preventing cancer rather than just detecting it early. Cervical cancer screening via Pap smears and HPV testing has been one of the greatest public health successes of the 20th century, reducing cervical cancer deaths by over 50 percent in countries with organized screening.
Lung cancer screening via low-dose CT scans is recommended for heavy smokers aged 50 to 80. Prostate cancer screening via PSA blood testing remains controversial because of high rates of overdiagnosis — many prostate cancers grow so slowly they would never cause harm.
What Biden's Case Illustrates
Joe Biden's cancer diagnosis at age 83 has brought attention to cancer in older adults, where treatment decisions are complicated by age, overall health, and quality-of-life considerations. Jill Biden noted that she observed a symptom before the diagnosis, underscoring the importance of paying attention to bodily changes regardless of screening schedules. Screening programs are designed for populations. Individual symptoms always warrant investigation, regardless of whether someone is due for their next screening test.
The Edge Review explains health concepts for general readers. Screening guidelines vary by country and individual risk; consult a healthcare provider for personal recommendations.